Log in
Enquire now
Ensoma, Inc.

Ensoma, Inc.

Ensoma, Inc. is an in vivo Gene Therapy founded in 2019.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
CEO
Emile Nuwaysir
Emile Nuwaysir
CIK Number
1,846,902
Legal Name
Ensoma, Inc.
Company Operating Status
Active
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...n/ensoma
CTO
‌
Daniel LeBlanc (settler)
Date Incorporated
2019
Email Address
katie@1abmedia.com
Founded Date
2019
Industry
Biomedical engineering
Biomedical engineering
Biology
Biology
Genomics
Genomics
‌
Genome editing
Tissue engineering
Tissue engineering
Healthcare
Healthcare
Regenerative medicine
Regenerative medicine
Engineering
Engineering
Biotechnology
Biotechnology
Drug discovery
Drug discovery
•••
Investors
Alexandria Venture Investments
Alexandria Venture Investments
‌
Symbiosis
RIT Capital Partners
RIT Capital Partners
Viking Global Investors
Viking Global Investors
5AM Ventures
5AM Ventures
Takeda Ventures
Takeda Ventures
Cormorant Asset Management
Cormorant Asset Management
F-Prime Capital Partners
F-Prime Capital Partners
Cormorant Capital
Cormorant Capital
Latest Funding Round Date
February 2021
Latest Funding Type
Series A
Series A
Legal classification
Corporation
Corporation
LinkedIn URL
@company/ensomabio
Location
Copenhagen
Copenhagen
Boston
Boston
Number of Employees
78
Number of Employees (Ranges)
51 – 200
0
Pitchbook URL
pitchbook.com/profiles...460025-56
Place of Incorporation
Delaware
Delaware
Technologies Used
CRISPR
CRISPR
Total Funding Amount (USD)
70,549,902
Twitter URL
@EnsomaBio
Official Website
ensoma.com
twelve.bio

Find more companies like Ensoma, Inc.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.